ProxsysRx Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 97


  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $14.6M

  • Investors
  • 2

ProxsysRx General Information


Provider of retail pharmacy management services intended to eliminate financial risk and maximize 340B savings and revenue for health systems. The company offers comprehensive pharmacy management, including drug sourcing, staffing, compliance and 340B program optimization, enabling health systems to generate significant revenue from their 340B eligibility without taking on any financial risk, while also benefiting patients through improved pharmacy services and access to critical medications.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Other Healthcare Technology Systems
Practice Management (Healthcare)
Enterprise Systems (Healthcare)
Parent Company
Corporate Office
  • 1500 Urban Center Drive
  • Suite 530
  • Birmingham, AL 35242
  • United States
+1 (205) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProxsysRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 18-Nov-2020 $14.6M 000.00 000.00 Completed Generating Revenue
2. Debt - PPP 29-Apr-2020 00.000 Completed Generating Revenue
1. Merger/Acquisition 21-Jul-2011 $36M 0000 Completed Generating Revenue
To view ProxsysRx’s complete valuation and funding history, request access »

ProxsysRx Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1 00,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series A 0,000,000 00.000000 00.00 000.00 000.00 00 000.00 00.000
To view ProxsysRx’s complete cap table history, request access »

ProxsysRx Comparisons

HQ Location
Total Raised
Post Valuation
Provider of retail pharmacy management services intended to eliminate financial risk and maximize 340B savings and reven
Other Healthcare Services
Birmingham, AL
97 As of 2024
000.00 0000-00-00
00000000000 000.00


adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliq
00000000 0000000000
San Diego, CA


iqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
0000000000 0000000 (
Deerfield Beach, FL
000 As of 0000
00000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ProxsysRx Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SUNRx Formerly PE-Backed San Diego, CA 000000&0
Sentry Data Systems Formerly PE-Backed Deerfield Beach, FL 000 000.00 000000&0 000.00
You’re viewing 2 of 2 competitors. Get the full list »

ProxsysRx Executive Team (7)

Name Title Board Seat Contact Info
George Salem Founder, Chairman & Chief Executive Officer
Thomas Nelson Jr. Chief Financial Officer
Billy Calhoun Chief Operating Officer
Marc Calhoun Chief Strategy Officer
Micah Russell Chief Development Officer
You’re viewing 5 of 7 executive team members. Get the full list »

ProxsysRx Board Members (6)

Name Representing Role Since
Arlen Reynolds ProxsysRx Board Member 000 0000
Gene Page Jr. ProxsysRx Vice Chairman & Board Member 000 0000
George Lazenby IV Self Board Member 000 0000
George Salem ProxsysRx Founder, Chairman & Chief Executive Officer 000 0000
Thomas Greer Fulcrum Equity Partners Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

ProxsysRx Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProxsysRx Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
FCA Venture Partners Venture Capital Minority 000 0000 000000 0
To view ProxsysRx’s complete investors history, request access »

ProxsysRx FAQs

  • When was ProxsysRx founded?

    ProxsysRx was founded in 2004.

  • Who is the founder of ProxsysRx?

    George Salem is the founder of ProxsysRx.

  • Who is the CEO of ProxsysRx?

    George Salem is the CEO of ProxsysRx.

  • Where is ProxsysRx headquartered?

    ProxsysRx is headquartered in Birmingham, AL.

  • What is the size of ProxsysRx?

    ProxsysRx has 97 total employees.

  • What industry is ProxsysRx in?

    ProxsysRx’s primary industry is Other Healthcare Services.

  • Is ProxsysRx a private or public company?

    ProxsysRx is a Private company.

  • What is the current valuation of ProxsysRx?

    The current valuation of ProxsysRx is 000.00.

  • What is ProxsysRx’s current revenue?

    The current revenue for ProxsysRx is 00000.

  • How much funding has ProxsysRx raised over time?

    ProxsysRx has raised $14.6M.

  • Who are ProxsysRx’s investors?

    FCA Venture Partners has invested in ProxsysRx.

  • Who are ProxsysRx’s competitors?

    SUNRx and Sentry Data Systems are competitors of ProxsysRx.

  • When was ProxsysRx acquired?

    ProxsysRx was acquired on 18-Nov-2020.

  • Who acquired ProxsysRx?

    ProxsysRx was acquired by Athenahealth.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »